Novonesis A S ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 328,812 | 372,573 | 262,848 | 280,856 | 162,043 |
| Receivables | 1,028,398 | 992,392 | 999,561 | 869,489 | 621,020 |
| Inventories | 867,324 | 907,706 | 769,371 | 740,261 | 526,640 |
| Other current assets | 62,069 | 56,647 | 18,226 | 55,998 | 64,178 |
| TOTAL | $2,286,602 | $2,329,317 | $2,050,006 | $1,946,604 | $1,373,882 |
| Non-Current Assets | |||||
| PPE Net | 3,353,574 | 3,217,270 | 3,071,058 | 3,086,719 | 1,789,590 |
| Investments And Advances | 24,079 | 22,931 | 23,915 | 27,676 | 29,766 |
| Intangibles | 7,248,232 | 6,986,475 | 5,830,385 | 5,999,302 | 0 |
| Other Non-Current Assets | 6,143,625 | 6,062,534 | 4,887,613 | 5,364,793 | 929,135 |
| TOTAL | $16,769,510 | $16,289,210 | $13,812,970 | $14,478,490 | $2,748,491 |
| Total Assets | $19,056,110 | $18,618,530 | $15,862,970 | $16,425,090 | $4,122,373 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 354,177 | 393,914 | 452,900 | 987,194 | 447,652 |
| Accounts payable and accrued liabilities | 348,566 | 342,944 | 334,592 | 372,392 | 234,643 |
| Other current liabilities | 531,031 | 448,518 | 310,677 | 300,024 | 317,843 |
| TOTAL | $1,416,707 | $1,329,433 | $1,232,806 | $1,755,993 | $1,054,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,278,297 | 3,376,879 | 1,336,997 | 1,154,975 | 628,571 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 7,841 |
| Other Non-Current Liabilities | 170,192 | 165,059 | 147,912 | 143,981 | 70,695 |
| TOTAL | $5,080,624 | $5,093,756 | $2,798,623 | $2,817,816 | $984,166 |
| Total Liabilities | $6,497,331 | $6,423,188 | $4,031,428 | $4,573,810 | $2,038,608 |
| Shareholders' Equity | |||||
| Common Shares | 146,697 | 142,581 | 132,320 | 135,366 | 81,602 |
| Retained earnings | 12,903,140 | 12,528,860 | 11,803,730 | 11,737,890 | 1,997,226 |
| Other shareholders' equity | -491,057 | -476,101 | -104,510 | -21,976 | 4,937 |
| TOTAL | $12,558,780 | $12,195,340 | $11,831,540 | $11,851,280 | $2,083,765 |
| Total Liabilities And Equity | $19,056,111 | $18,618,528 | $15,862,968 | $16,425,090 | $4,122,373 |